Title |
Development and characterization of a packaging cell line for pseudo-infectious yellow fever virus particle generation
|
---|---|
Published in |
Revista da Sociedade Brasileira de Medicina Tropical, February 2018
|
DOI | 10.1590/0037-8682-0220-2017 |
Pubmed ID | |
Authors |
Sabrina Ribeiro de Almeida Queiroz, José Valter Joaquim Silva, Andréa Nazaré Monteiro Rangel da Silva, Amanda Gomes de Oliveira Carvalho, Jefferson José da Silva Santos, Laura Helena Vega Gonzales Gil |
Abstract |
Pseudo-infectious yellow fever viral particles (YFV-PIVs) have been used to study vaccines and viral packaging. Here, we report the development of a packaging cell line, which expresses the YFV prM/E proteins. HEK293 cells were transfected with YFV prM/E and C (84 nt) genes to generate HEK293-YFV-PrM/E-opt. The cells were evaluated for their ability to express the heterologous proteins and to package the replicon repYFV-17D-LucIRES, generating YFV-PIVs. The expression of prM/E proteins was confirmed, and the cell line trans-packaged the replicon for recovery of a reporter for the YFV-PIVs. HEK293-YFV-prM/E-opt trans-packaging capacity demonstrates its possible biotechnology application. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 25% |
Switzerland | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 14 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 3 | 21% |
Other | 2 | 14% |
Researcher | 2 | 14% |
Student > Master | 2 | 14% |
Student > Bachelor | 1 | 7% |
Other | 1 | 7% |
Unknown | 3 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 3 | 21% |
Medicine and Dentistry | 3 | 21% |
Chemical Engineering | 2 | 14% |
Immunology and Microbiology | 1 | 7% |
Social Sciences | 1 | 7% |
Other | 1 | 7% |
Unknown | 3 | 21% |